These FAQs are by no means exhaustive. If you are interested in working with us, or finding out more about how FMT has affected patient outcomes, please contact us.
Not as a generality. Every patient responds differently and every condition needs a unique approach. Therefore there cannot be any standardised “prescriptive” approach to ongoing therapies after a patient returns home. It is not a “one-size-fits-all” situation. Each patient needs to find which approach works best for them in their own unique environment, whether it is daily, weekly or monthly. Only the patient’s own response can provide evidence for the correct program for them and we help them design a schedule of top-ups which may be the most beneficial for them. It does have to remain flexible to adjust to a patient’s needs and symptom response long term.
We have a page on our website with links to a few key studies about FMT – click this link for details:
The internet is a huge library of information and to locate the more serious scientific publications, we recommend the use of a specific search tool called Search Visualizer: www.searchvisualizer.com
Insert your search terms and make sure you use the word ‘abstract’ also, this will ensure that your search results contain mainly scientific studies which nearly always feature a small synopsis at the front, called an abstract.
e.g. FMT Crohn’s abstract
We have observed that in the case of advanced and acute inflammation, it is possible, although uncommon for a commensal species of bacterium causing no problems whatsoever in the donor, to exacerbate the inflammation in the recipient. In most instances the inflammation appears to reduce without the need for pharmaceutical intervention. On rare occasions patients return to their own medical physicians to control the inflammation. In general terms, commensal microflora are a part of normal daily life in the donor and if the donor is tested negative for important pathogenic infections and conditions, then the same microflora should in most cases, transplant safely into a donor without complications. We have seen no documented cases of major side effects.
Of course, each individual implant can be individually tested on request, but at a cost of almost £1000 GBP for each test program, this would make a £3,000/5-day program cost £8,000 and a £4,000/10-day program would cost £14,000. Instead, we test every three months and use implants taken between negative opening and closing tests.
Parents of children can you please read this very carefully
Under United Kingdom law, only pediatrician’s holding a current medical licence can treat a child under the age of 16 years of age with the procedure that is utilised. At this moment the Taymount Clinic CANNOT treat children under the age of 16 years under any circumstances.
This situation will change when we engage a Paediatrician to consult at the clinic, so until then – we are sorry, we cannot treat children or even provide other advice to parents. It is a highly emotive subject and we fully understand parents’ desperation when they contact us for advice, but FMT is still in an ongoing research phase and UK law has a strong view on parents who may attempt a non-clinical and “experimental” home treatment on a child.
We are a private clinic with no connection to the UK NHS. Any UK NHS patient wishing to have this treatment paid for by the NHS will have to directly approach their own doctor to ask if their area CCG – Clinical Commissioning Group (formerly called a PCT – Primary Care Trust) will fund their treatment from the local health budget. The Taymount Clinic can not do this on a patient’s behalf. As of this date we need to report that no CCG in the UK has offered to fund a patient’s treatment. We have had two patient referrals from leading NHS Gastroenterologists in the UK, but they are on the basis that the patient funds their own treatment program.
FMT is currently at the investigative stage and to the most part, microbiologists and academics are carrying out the research work into the effectiveness and relevance of the procedure with a range of conditions. The United Kingdom medical authorities do not classify FMT as a medical procedure, although once the research has reached an advanced state with sufficient positive trials data, medical adoption is likely to follow.
In preparation for medical adoption, treatment at the Taymount Clinic is carried out by trained FMT practitioners with nutritional experience.
Some FMT researchers use a ‘Top-Down” process where a nasogastric tube is inserted and tracked down through the esophagus and stomach, sometimes into the duodenum. For a number of reasons (which include patient comfort) we prefer to use a rectal catheter infusion of the implant that delivers the FMT directly to the large bowel (colon).